HTLV-I-infected T cells activate autologous CD4+ T cells susceptible to HTLV-I infection in a co-stimulatory molecule-dependent fashion

A vigorous production of human T lymphotropic virus type I (HTLV-I)-infected CD4⁺ T cells is closely associated with the development of adult T cell leukemia (ATL) and neurological disease. However, the immunological mechanisms leading to generation of the HTLV-I-infected cells are not fully clarified. The modulation of CD80 and CD86 expression on the HTLV-I-infected cells and its physiological role in the interaction of infected CD4⁺ T cells with uninfected CD4⁺ T cells was examined. The HTLV-I-infected CD4⁺ T cell lines established from ATL patients and normal donors by infecting their CD4⁺ T cells with the virus expressed CD80, CD86, and HLA-DR, and induced a proliferation of autologous and allogenic CD4⁺ T cells. While the CD4⁺ T cells stimulated with the autologous HTLV-I-infected cells for 7 days expressed CD80 and CD86 but not HTLV-I gene products, they expressed HTLV-I gag antigen after 4 weeks. The interaction of HTLV-I-infected and -uninfected CD4⁺ T cells was profoundly suppressed by a combination of CD80 and CD86 monoclonal antibodies. These results suggest that the induction of CD80 and CD86 on HTLV-I-infected CD4⁺ T cells participates actively in the generation of the virus-infected progenitor cells.     

Activation requirements and responses to TLR ligands in human CD4 T cells: Comparison of two T cell isolation techniques

Direct regulation of T cell function by microbial ligands through Toll-like receptors (TLR) is an emerging area of T cell biology. Currently either immunomagnetic cell sorting (IMACS) or fluorescence-activated cell sorting (FACS), are utilized to isolate T-cell subsets for such studies. However, it is unknown to what extent differences in T cell purity between these isolation techniques influence T cell functional assays. We compared the purity, response to mitogen, activation requirements, and response to TLR ligands between human CD4⁺ T cells isolated either by IMACS (IMACS-CD4⁺) or by IMACS followed by FACS (IMACS/FACS-CD4⁺). As expected, IMACS-CD4⁺ were less pure than IMACS/FACS-CD4⁺ (92.5% ± 1.4% versus 99.7% ± 0.2%, respectively). Consequently, IMACS-CD4⁺ proliferated and produced cytokines in response to mitogen alone and had lower activation requirements compared to IMACS/FACS-CD4⁺. In addition IMACS-CD4⁺ but not IMACS/FACS-CD4⁺ responses were upregulated by the TLR-4 ligand lipopolysaccharide (LPS). On the other hand, TLR-2 and TLR-5 engagement induced costimulation in both IMACS-CD4⁺ and highly purified IMACS-/FACS-CD4⁺. Altogether these results indicate that small differences in cell purity can significantly alter T cell responses to TLR ligands. This study stresses the importance of a stringent purification method when investigating the role of microbial ligands in T cell function.